Race Oncology Ltd. (AU:RAC) has released an update.
Race Oncology Ltd has notified the cessation of two sets of options due to unmet conditions, effective from September 1, 2024. Investors are informed that 139,516 options with an expiry of December 2028 and 58,263 options with a March 2028 expiry will no longer be valid. This may affect market perceptions and the future financial strategy of the company’s stockholders.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.
